Skip to main content

Table 5 Predictors of non HDL-C goal attainment

From: First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients

  Initial model Final model
  OR (95% CIs) P-value OR (95% CIs) P-value
Male gender 1.04 (0.50-2.17) 0.9   
Age 1.01 (0.98-1.05) 0.4   
DM 0.78 (0.33-1.87) 0.6   
Smoking 0.65 (0.31-1.36) 0.2   
CAD 1.61 (0.75-3.45) 0.2 1.80 (0.95-3.42) 0.07
PAD 1.71 (0.62-4.66) 0.3   
Cerebrovascular disease 0.64 (0.17-2.35) 0.5   
Baseline LDL-C (mg/dl) 0.98 (0.97-0.99) 0.001 0.98 (0.97-0.99) <0.001
Combined therapy with statin and ezetimibe 1.92 (0.81-4.56) 0.1   
Very high potency LDL-C lowering regimen 1.06 (0.36-3.10) 0.9   
Fenofibrate 1.05 (0.34-3.42) 0.9   
n3 fatty acids     
  1. DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.